Biotechnology FDA Mandates “Boxed Warning” For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies – Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Johnson & Johnson’s Carvykti Stands Ahead Of Bristol Myers’ Rival Blood Cancer Therapy With FDA Approval For Wider Population – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Why Is 2seventy bio Stock Trading Higher On Monday? – Legend Biotech (NASDAQ:LEGN), Johnson & Johnson (NYSE:JNJ), 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology FDA To Review Two Cell Therapies For Multiple Myeloma This Week – Johnson & Johnson And Bristol-Myers – Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Arcellx’s Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson’s Multiple Myeloma Cell Therapies: Morgan Stanley – Arcellx (NASDAQ:ACLX) Read more
